(Reuters) – China's food and drug regulator said late on Monday it had rejected applications for 13 new drugs, citing false or incomplete trial data, as the government toughens enforcement of quality standards. The regulator's crackdown comes after it called on manufacturers to carry out their own internal investigations into trial data in July, a move expected to raise the quality of local drugs over the long-run, creating a challenge for global pharmaceutical firms.
Originally posted here:
China toughens drug quality standards, rejects 13 applications